Cannabinoids in skincare are hemp compounds, mostly CBD, added to creams, balms and serums because skin cells carry cannabinoid receptors. Lab studies show that CBD can affect oil production and inflammation signals in skin cells. Human trials are still few and small, so cosmetic claims rest mainly on laboratory work.
Key facts
- Main cannabinoid used
- CBD (cannabidiol), which is not intoxicating
- Why skin responds
- Skin cells have their own endocannabinoid system: receptors, signalling lipids and enzymes
- Evidence
- Mostly cell and animal studies; few controlled human trials on skin (as of October 2026)
- Skin penetration
- CBD passes through human skin in lab tests, faster when ethanol is in the formula
- UK legal status
- Pure CBD is not a controlled drug; THC is Class B, so skincare must stay within the legal limits (Home Office, as of October 2026)
Prefer watching? This video covers the main points.
How do cannabinoids in skincare work?
They work through the skin's own endocannabinoid system. The body makes signalling lipids, such as anandamide, that bind to cannabinoid receptors. A 2009 review found this system in keratinocytes, hair follicles and sebaceous glands. Its job there seems to be keeping skin cell growth, maturation and immune responses in balance (Bíró et al., 2009). Other lipids made by the body, such as oleamide, also act on cannabinoid receptors in lab tests.
Plant cannabinoids can act on the same system. They also reach other targets in skin, such as TRPV ion channels and PPAR receptors (Martins et al., 2022). Read more in our guide to the endocannabinoid system.
What does the research on CBD and skin show?
Most of it comes from the lab. In cultured human sebocytes, the cells that make skin oil, CBD reduced oil production and cell growth and dampened inflammation signals (Oláh et al., 2014). Reviews describe antioxidant, anti-inflammatory and moisturising properties in cell and animal studies (Kuzumi et al., 2024).
Human evidence is thin. A 2024 review counted only a few clinical studies on CBD in the skin (Kuzumi et al., 2024). A systematic review of skin-applied CBD trials found eight usable studies, mostly small, with a high risk of bias and CBD mixed with other ingredients (Scholfield et al., 2023). So no one can yet say what a given CBD cream does for a given skin.
Tolerability data are more reassuring. In patch tests on healthy volunteers, several CBD formulations caused no irritation or sensitisation (Maghfour et al., 2021).
Which cannabinoids are used in skincare?
CBD is by far the most common. It is not intoxicating, and it is the cannabinoid with the most research behind it. Some products add CBG or other minor cannabinoids, which have been studied far less.
THC is a different case. In the UK, THC is a Class B drug, and a product that contains it is controlled unless it meets the "exempt product" definition (Home Office, 2024). Hemp seed oil, often listed as Cannabis sativa seed oil, contains little or no cannabinoids. It is a moisturising oil, not a source of CBD.
| Ingredient | What it is | Research on skin |
|---|---|---|
| CBD (cannabidiol) | Main non-intoxicating cannabinoid in hemp | Cell studies on oil glands and inflammation; few small human trials |
| CBG (cannabigerol) | Minor cannabinoid, precursor of others | Mostly laboratory studies |
| THC | Intoxicating cannabinoid | Class B drug in the UK; strict limits apply |
| Hemp seed oil | Oil pressed from the seeds | Used as an emollient; contains little or no CBD |
Does CBD get through the skin?
Some of it does. In a lab study on human skin, CBD passed through about ten times more easily than Δ8-THC, and adding ethanol increased the flow (Stinchcomb et al., 2004). How far it gets in an everyday cream depends on the formula: the carrier oils, the emulsion and the other ingredients.
That is why formulation matters as much as the CBD figure on the label. Cannabinoids break down with light, heat and air, so stable packaging and storage count too.
How do you choose a CBD skincare product?
Look for facts you can check:
- The label should state milligrams of CBD per pack, not just "hemp" or "cannabis".
- It should say whether the extract is isolate, broad spectrum or full spectrum. Our guide to full spectrum, broad spectrum and isolate explains the difference.
- A certificate of analysis should be available for the batch you buy. See how to read a certificate of analysis.
- An independent cosmetics standard, such as COSMOS, tells you how the ingredients were sourced and processed.
Be wary of creams sold with medical promises. A cosmetic may not make medical claims, and the research would not back them up yet.
From our production
Our CBD skincare line holds COSMOS ORGANIC certification. We test every batch in Switzerland, and we have never had a failed test since 2013.
— Robin Roy Krigslund-Hansen, co-founder and CEO
You can see the range in our CBD creams and balms, and our CBD cream guide covers how to use them.
Frequently asked questions
How do cannabinoids in skincare work?
Skin cells have their own endocannabinoid system, with receptors in keratinocytes, hair follicles and oil glands. Cannabinoids such as CBD act on these receptors and on related targets such as TRPV channels. Most of this comes from laboratory studies.
Is there evidence that CBD skincare works?
The evidence is limited. Cell studies show effects on oil production and inflammation signals, but there are only a few small human trials on skin, and a systematic review rated their risk of bias as high.
Can CBD skincare make you high?
No. CBD is not intoxicating. In the UK, THC is a Class B drug, so CBD cosmetics sold legally must stay within the limits for controlled cannabinoids.
Is hemp seed oil the same as CBD?
No. Hemp seed oil is pressed from the seeds and contains little or no CBD. It is used as a moisturising oil. CBD comes from the flowers and leaves of the hemp plant.
Is CBD skincare safe for sensitive skin?
In patch tests on healthy volunteers, several CBD formulations caused no irritation or sensitisation. Other ingredients can still irritate, so test a small area first and stop if your skin reacts.
This article summarises published research. It is not medical advice. Formula Swiss CBD oils are sold as cosmetics for use on the skin. They are not food supplements or medicines and are not intended to diagnose, treat, cure or prevent any disease.
Last reviewed:
Sources
- Bíró T, Tóth BI, Haskó G, Paus R, Pacher P. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci 2009;30(8):411–420. doi:10.1016/j.tips.2009.05.004
- Martins AM, Gomes AL, Vilas Boas I, Marto J, Ribeiro HM. Cannabis-based products for the treatment of skin inflammatory diseases: a timely review. Pharmaceuticals (Basel) 2022;15(2):210. doi:10.3390/ph15020210
- Oláh A, Tóth BI, Borbíró I, et al. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. J Clin Invest 2014;124(9):3713–3724. doi:10.1172/JCI64628
- Kuzumi A, Yoshizaki-Ogawa A, Fukasawa T, Sato S, Yoshizaki A. The potential role of cannabidiol in cosmetic dermatology: a literature review. Am J Clin Dermatol 2024;25(6):951–966. doi:10.1007/s40257-024-00891-y
- Scholfield CN, Waranuch N, Kongkaew C. Systematic review on transdermal/topical cannabidiol trials: a reconsidered way forward. Cannabis Cannabinoid Res 2023;8(4):589–602. doi:10.1089/can.2021.0154
- Maghfour J, Rietcheck H, Szeto MD, et al. Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single-centre randomized evaluator-blinded clinical and in vitro studies in normal skin. Clin Exp Dermatol 2021;46(8):1518–1529. doi:10.1111/ced.14749
- Stinchcomb AL, Valiveti S, Hammell DC, Ramsey DR. Human skin permeation of Δ8-tetrahydrocannabinol, cannabidiol and cannabinol. J Pharm Pharmacol 2004;56(3):291–297. doi:10.1211/0022357022791
- Home Office. Drug licensing factsheet: cannabis, CBD and other cannabinoids (updated 3 October 2024). gov.uk